These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37666696)

  • 21. Adverse Event Following Immunization (AEFI) in Children: An Analysis of Reporting in VigiAccess.
    Pandey D; Mehta G; Sachdeva M; Tripathi R
    Drug Res (Stuttg); 2022 Oct; 72(8):435-440. PubMed ID: 35724674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005-2017.
    Yoon D; Kim JH; Lee H; Shin JY
    Yonsei Med J; 2020 Jul; 61(7):623-630. PubMed ID: 32608206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse Events Following Immunization- The Known Unknowns and Black Box : Based on 10th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 9th Oct. 2022.
    Das MK
    Indian J Pediatr; 2023 Aug; 90(8):817-825. PubMed ID: 37233889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial.
    Tsafack M; Ateudjieu J
    Pan Afr Med J; 2015; 22():351. PubMed ID: 26985269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    Hills SL; Soeung SC; Sarath S; Morn C; Dara C; Fischer M; Thigpen MC
    PLoS One; 2022; 17(6):e0269480. PubMed ID: 35679297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana.
    Yamoah P; Mensah KB; Padayachee N; Bangalee V; Oosthuizen F
    Hum Vaccin Immunother; 2023 Dec; 19(1):2199654. PubMed ID: 37127290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of adverse events following immunization during pregnancy and the newborn period.
    Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB
    Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records.
    Ishaku SG; Umeh G; Adzu B; Onimisi A; Dauda M; Iyal HA; Iliyasu N; Sunday DJ; Daikwo J; Yates SM; Ibrahim II; Samaila LH; Abdullahi B; Parom SK; Maiwashi KY; Zakari F; Nuhu KS
    Pan Afr Med J; 2021; 40():268. PubMed ID: 35251462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events following immunization reporting and impact on immunization services in informal settlements in Nairobi, Kenya: a prospective mixed-methods study.
    Malande OO; Munube D; Afaayo RN; Chemweno C; Nzoka M; Kipsang J; Musyoki AM; Meyer JC; Omayo LN; Owino-Okongo L
    Pan Afr Med J; 2021; 40():81. PubMed ID: 34909070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons on causality assessment and communications from the 2019 South-East Asia Regional (SEAR) workshop on inter-country expert review of selected Adverse Events Following Immunization (AEFI) cases.
    MacDonald NE; Guichard S; Arora N; Menning L; Wilhelm E;
    Vaccine; 2020 Jul; 38(32):4924-4932. PubMed ID: 31611095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
    Chitkara AJ; Thacker N; Vashishtha VM; Bansal CP; Gupta SG
    Indian Pediatr; 2013 Aug; 50(8):739-41. PubMed ID: 24036641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China.
    Lv H; Pan X; Wang Y; Liang H; Yu H
    Hum Vaccin Immunother; 2022 Nov; 18(5):2083865. PubMed ID: 35820038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
    Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
    Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression.
    Lopes SRC; Perin JLR; Prass TS; Carvalho SMD; Lessa SC; Dórea JG
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29865181
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.
    Dodoo AN; Renner L; van Grootheest AC; Labadie J; Antwi-Agyei KO; Hayibor S; Addison J; Pappoe V; Appiah-Danquah A
    Drug Saf; 2007; 30(4):347-56. PubMed ID: 17408311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events.
    Noh Y; Ko HY; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Shin JY
    Epidemiol Health; 2023; 45():e2023054. PubMed ID: 37309115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017.
    Johnson K; Anyoti H; Coulby C
    Can Commun Dis Rep; 2018 Dec; 44(12):324-330. PubMed ID: 31517950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.